Document Detail

Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease.
MedLine Citation:
PMID:  17893004     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Adiponectin is considered to have anti-inflammatory, insulin-sensitizing, and antiatherosclerotic properties. In the present prospective study, the relationship between metabolic syndrome (Adult Treatment Panel III) and adiponectin plasma levels and the relationship between plasma adiponectin levels and future cardiovascular events were investigated. METHODS: A case-cohort study of 431 patients with clinical evident vascular disease from the Second Manifestations of ARTerial Disease study. The relationship between adiponectin plasma levels and new vascular events was investigated with Cox regression, adjusted for potential confounders and effect modifiers (age, sex, renal function [modification of diet in renal disease], body mass index, high sensitive C-reactive protein, use of angiotensin converting enzyme-inhibition and/or AII antagonists, and presence of metabolic syndrome or impaired renal function). RESULTS: Plasma adiponectin levels were lower in patients with metabolic syndrome as compared with patients without (7.9 +/- 0.3 vs 5.2 +/- 0.3 microg/mL) and decreased with the number of components. During a mean follow-up of 2.3 years, 216 patients had a new cardiovascular event. Lower adiponectin plasma levels were associated with a lower risk for future cardiovascular events (hazard ratio 0.50, 95% confidence interval 0.25-0.99). This relationship was not influenced by renal function, body mass index, and renin-angiotensin system-blocking agents or modified by metabolic syndrome and impaired renal function. CONCLUSION: In patients with clinical evident vascular disease, lower adiponectin levels were associated with a lower cardiovascular risk. Therefore, it may be hypothesized that the potential antiatherosclerotic properties of adiponectin do not apply for patients with already established vascular disease.
Gideon R Hajer; Yolanda van der Graaf; Jobien K Olijhoek; Michael Edlinger; Frank L J Visseren
Related Documents :
10195874 - Cardiovascular risk factors and diseases after renal transplantation.
12595514 - Cd4 cell lymphopenia and atherosclerosis in renal transplant recipients.
16014044 - Mild renal insufficiency is associated with increased left ventricular mass in men, but...
10928294 - Cardiac and vascular abnormalities in renal transplant patients: differential effects o...
6987514 - Association of mb compatibility with successful intrafamilial kidney transplantation.
10435364 - Anorexia nervosa with severe liver dysfunction and subsequent critical complications.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  American heart journal     Volume:  154     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-09-25     Completed Date:  2007-11-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  750.e1-7     Citation Subset:  AIM; IM    
Department of Vascular Medicine, UMC Utrecht, Utrecht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adiponectin / blood*
Aortic Rupture / blood,  epidemiology
Cardiovascular Diseases / blood*,  epidemiology
Case-Control Studies
Metabolic Syndrome X / blood*,  complications
Middle Aged
Prospective Studies
Renal Insufficiency / blood,  epidemiology
Risk Assessment
Vascular Diseases / blood*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction...
Next Document:  Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloprotein...